At a CAGR of 17.1% Non Invasive Prenatal Testing (NIPT) Market will reach $13.1 billion in 2027.

Meticulous Research- leading global market research company published a research report titled "Non Invasive Prenatal Testing (NIPT) Market by Product & Solution (Consumables, Systems, Software), Method (Ultrasound Screening, Cell Free DNA Test), Application (Trisomy, Microdeletions, Monosomy), and End-user (Diagnostic Labs) - Global Forecast to 2027".

According to this latest publication from Meticulous Research, the global non-invasive prenatal testing market is expected to grow at a CAGR of 17.1% from 2019 to reach $13.1 billion by 2027.

Get Your Sample Report Now! @ http://bit.ly/39efgS1

The high growth of non-invasive prenatal testing market is mainly attributed to the high risk of chromosomal abnormalities with increasing maternal age, rise in occurrences of chromosomal aneuploidies among fetus, development of advanced and new technologies and non-invasive parenteral testing products, and improving reimbursement scenario for NIPT. In addition, rising awareness regarding non-invasive prenatal testing and untapped market opportunity in emerging markets offer significant growth opportunities for the players operating in this market. However, strict regulatory guidelines and ethical hurdles are some of the key factors challenging the adoption of non-invasive prenatal testing products over the coming years.

On the basis of products and solutions, the kits/consumables segment commanded the largest share of the overall NIPT market in 2019, mainly due to increasing incidences of chromosomal abnormalities, rise in the number of tests and products for NIPT, and improvement of approvals or licenses for assays.

On the basis of application, trisomy segment accounted for the largest share of the overall NIPT market in 2019. The large share of this segment is mainly attributed to the factors such as the increasing maternal age and rising incidence of chromosomal abnormalities.

On the basis of end user, diagnostic laboratories segment accounted for the largest share of the overall NIPT market in 2019, as the large volume of NIPT testing done at diagnostic laboratories owing to availability of the well-equipped facility and availability of trained/skilled laboratory technicians. The initiatives taken by diagnostic laboratories to provide high quality testing services is further driving the growth in this market.

To get all of the details about this research, click on the link below. @ http://bit.ly/3bctK6D

This research report analyzes major geographies and provides a comprehensive analysis for North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, India, and RoAPAC), Latin America, and the Middle East & Africa. North America commanded the largest share of the global non-invasive prenatal testing market in 2019, followed by Europe and Asia-Pacific regions. High diagnostic and treatment rate of trisomy disorders and the emergence of key organizations in the U.S. are accelerating the non-invasive prenatal testing market in the North American region.

Key Players:

The key players operating in the global non-invasive prenatal testing market are Agilent Technologies, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), PerkinElmer, Inc. (Massachusetts), Illumina, Inc. (U.S.), Beijing Genomics Institute (China), Eurofins LifeCodexx AG (Germany), NATERA, INC. (U.S.), Igenomix SL (Spain), Laboratory Corporation of America Holdings (U.S.), F. Hoffman-La Roche Ltd. (Switzerland), GE Healthcare (U.S.), and Yourgene Health (U.K.) among others.

Buy Premium Research Report @ http://bit.ly/2Ot1LG8

Key questions answered in the report-

Which are the high growth market segments in terms of product & solutions, method, application, end-users, and region/countries?
What was the historical market for non-invasive prenatal testing across the globe?
What are the market forecasts and estimates for the period 2019-2027?
What are the major drivers, restraints, opportunities, and trends in the global non-invasive prenatal testing market?
Who are the major players in the non-invasive prenatal testing market?
How is the competitive landscape and who are the market leaders in the global non-invasive prenatal testing market?
What are the different strategies adopted by the major players in the global non-invasive prenatal testing market?
What are the geographical trends and high growth regions/ countries?

Fill the form to gain deeper insights on this market
http://bit.ly/2ucU5Rw

Connect with us

Asia-Pacific
Office No-202, 203,204,205,206;
2nd Floor, Pushpak Business Hub,
Wakad, Pimpri-Chinchwad,
411057, India.
For Sales Enquires
India: +91-744-7780008
U.S.: +1-646-781-8004
U.K.: +44-203-868-8738

About Meticulous Research

Meticulous Research was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, with the help of its unique research methodologies, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa regions.

With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges f sustainable growth.

This release was published on openPR.